National and subnational burden of XDR-TB in China,1990-2023: Long-term trends, regional disparities, and projections, 2024-2050 [0.03%]
中国1990-2023年耐多药结核病（XDR-TB）的国家和次国家级疾病负担：长期趋势、地区差异及2024-2050年的预测
Shunxian Zhang,Jinlei Qi,Jinxin Zheng et al.
Shunxian Zhang et al.
Objectives: China still faces a heavy Tuberculosis (TB) burden; extensively drug-resistant tuberculosis (XDR-TB) prevalence rises sharply amid overall TB decline, with no national/provincial comprehensive assessment of it...
High burden of autochthonous arboviral infections during the summer season in Verona province, Italy, during 2025 [0.03%]
意大利维罗纳省2025年夏季地方性虫媒病毒感染高负担
Dora Buonfrate,Leonardo Ancillotti,Chiara Zanchi et al.
Dora Buonfrate et al.
Objectives: We aimed at estimating the frequency of local transmission of arboviral infections in Verona province, Italy, between June and September 2025. ...
Immunogenicity and efficacy over 12 months following a fourth dose of a bivalent mRNA or protein-based COVID-19 vaccine: A randomised controlled trial in Australia [0.03%]
第四剂mRNA或蛋白质基新冠疫苗的免疫原性和疗效：澳大利亚一项随机对照试验中的12个月结果
Nadia Mazarakis,Zheng Quan Toh,Eleanor Neal et al.
Nadia Mazarakis et al.
Objectives: We report immunogenicity, safety, and efficacy over 12 months following a fourth COVID-19 mRNA or protein vaccine dose. Methods: ...
Randomized Controlled Trial
The Journal of infection. 2026 Apr;92(4):106727. DOI:10.1016/j.jinf.2026.106727 2026
Trends, Antimicrobial Resistance, and Source Attribution of Campylobacter jejuni and C. coli in Beijing: An 8-Year Molecular Surveillance Study [0.03%]
北京8年分子监测研究中的jejuni和coli的流行趋势、抗微生物药物耐药性及来源追溯
Penghang Zhang,Yuzhu Liu,Bowenxin Wang et al.
Penghang Zhang et al.
Objectives: Beijing, a large urban center with complex food supply chains, faces increasing challenges from foodborne Campylobacter infections. However, local data on antimicrobial resistance, source attribution, and path...
Clade 2.3.4.4b H5N1 influenza A virus exhibits high infectivity in human respiratory tract models [0.03%]
H5N1流感病毒 clade 2.3.4.4b株具有高感染性及其关键氨基酸位点
Anna Löwa,Matthias Budt,Anita Balázs et al.
Anna Löwa et al.
Pneumococcal serotype epidemiology and resistance after PCV13 replacement with PCV10, Sweden [0.03%]
瑞典PCV13更换为PCV10后肺炎球菌血清型流行病学和耐药性的变化
Linda Yamba Yamba,Fabian Uddén,Silvana Dalence et al.
Linda Yamba Yamba et al.
Objectives: To evaluate the impact of the 2018 switch from PCV13 to PCV10 in Sweden's childhood immunisation programme on the serotype distribution of Streptococcus pneumoniae. ...
Traditional use of the term "epidemic cerebrospinal meningitis" limits the accuracy of invasive meningococcal disease epidemiological reporting in China [0.03%]
术语“流行性脑脊髓膜炎”限定了中国侵袭性流行性脑膜炎球菌疾病流行病学报告的准确性
Limin Dong,Qing Wang,Wei Shi et al.
Limin Dong et al.
Revisiting the evolutionary dynamics of Nipah virus with insights from phylogenetic analysis [0.03%]
基于系统发育分析重访 nipah 病毒的进化动态
Junxiang Zhao,Jiayi Wang,Leiliang Zhang
Junxiang Zhao
Identification of an emerging HIV-1 circulating recombinant form (CRF197_0108) in young populations in Yunnan, China [0.03%]
在中国云南年轻人群中识别一种新出现的HIV-1循环重组型(CRF197_0108)
Min Chen,Huichao Chen,Lijuan Dong et al.
Min Chen et al.
Effectiveness of the TYPHIBEV® (Vi-CRM197 conjugate) Vaccine Introduction in Nepal: A Test-Negative, Case-Control Study [0.03%]
奈帕威(Vi-CRM197结合疫苗)疫苗在尼泊尔的使用效果：病例对照研究
Dipesh Tamrakar,Sabin Bikram Shahi,Esther Jung et al.
Dipesh Tamrakar et al.
Objectives: We aimed to evaluate the effectiveness of TYPHIBEV®, which was introduced through a catch-up campaign and routine immunization in Nepal, in preventing blood culture-confirmed typhoid fever among children. ...